Franchise Group Inc logo

Franchise Group Inc (FRG)

Market Closed
16 Jan, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
29. 88
0
0%
$
1.05B Market Cap
- P/E Ratio
2.5% Div Yield
1.88M Volume
- Eps
$ 29.88
Previous Close
Add Transaction
Day Range
29.86 29.92
Year Range
29.86 29.92
Want to track FRG and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

FRG closed Thursday higher at $29.88, an increase of 0% from Wednesday's close, completing a monthly increase of 0% or $29.88. Over the past 12 months, FRG stock gained 0%.
FRG pays dividends to its shareholders, with the most recent payment made on Apr 14, 2023. The next estimated payment will be in 14 Jul 2023 on Jul 14, 2023 for a total of $0.625.
The last earnings report, released on Aug 06, 2024, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

FRG Chart

People also search for

Ani Pharmaceuticals Inc.
$ 77.65
-1.1206%
Harrow Inc.
$ 38.45
-8.1901%
Alliant Energy Corporation
$ 86.78
-2.0763%
Alvotech S.A.
$ 0.33
0%
Phibro Animal Health Corporation
$ 34.03
-0.0147%
Can Gilead's Efforts to Develop New Treatments Solidify HIV Franchise?

Can Gilead's Efforts to Develop New Treatments Solidify HIV Franchise?

GILD's HIV franchise gains momentum with strong Biktarvy and Descovy demand, Yeztugo growth and a promising pipeline targeting long-term expansion.

Zacks | 1 day ago
Hemab Therapeutics: A Cash-Rich Coagulation Franchise With Multiple Clinical Catalysts

Hemab Therapeutics: A Cash-Rich Coagulation Franchise With Multiple Clinical Catalysts

Hemab Therapeutics is building a differentiated coagulation franchise targeting underserved rare bleeding disorders with a prophylactic approach. COAG's robust cash position post-IPO funds operations into 2029, supporting multiple clinical catalysts across sutacimig, HMB-002, and preclinical HMB-003. Lead asset sutacimig shows strong Phase 2 efficacy and FDA-aligned Phase 3 dosing, while HMB-002 and HMB-003 broaden addressable markets.

Seekingalpha | 1 week ago
Zenas BioPharma: Obexelimab Could Build An Autoimmune Franchise

Zenas BioPharma: Obexelimab Could Build An Autoimmune Franchise

Zenas BioPharma (ZBIO) is positioned as more than a rare-disease play, leveraging obexelimab's B-cell inhibition platform for multiple autoimmune indications. ZBIO's Phase 3 INDIGO trial validates obexelimab in IgG4-RD, showing 56% flare reduction and improved safety versus placebo, supporting a differentiated mechanism. With $718.5M cash and milestone access, ZBIO expects runway through Q2 2029, enabling launch prep and expansion into SLE and MS indications.

Seekingalpha | 1 week ago

Franchise Group Inc (FRG) FAQ

What is the stock price today?

The current price is $29.88.

On which exchange is it traded?

Franchise Group Inc is listed on NASDAQ (NMS).

What is its stock symbol?

The ticker symbol is FRG.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 2.5%.

What is its market cap?

As of today, the market cap is 1.05B.

Has Franchise Group Inc ever had a stock split?

No, there has never been a stock split.

Franchise Group Inc Profile

Specialty Retail Industry
Consumer Discretionary Sector
Brian R. Kahn CFA CEO
NASDAQ (NMS) Exchange
35180X105 CUSIP
US Country
8,575 Employees
30 Jun 2023 Last Dividend
- Last Split
- IPO Date

Overview

Franchise Group, Inc. was initially known as Liberty Tax, Inc. before it rebranded in September 2019. Founded in 2010 and headquartered in Delaware, Ohio, it operates a vast array of franchised and franchisable businesses across six main segments: Vitamin Shoppe, Pet Supplies Plus, Badcock, American Freight, Buddy's, and Sylvan. These segments encompass a wide range of industry sectors from health and wellness, pet supplies, home furnishings, to education. On August 21, 2023, the corporation transitioned from a public entity to a privately held company. This strategic move underscores its evolution and growth in operating and franchising businesses with a significant footprint in their respective markets.

Products and Services

  • Vitamin Shoppe

    Functions as an omnichannel specialty retailer, offering a comprehensive selection of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. Its mission is to nurture and support the health and wellness journeys of its customers.

  • Pet Supplies Plus

    Operates both as a retail chain and franchisor providing a broad spectrum of pet supplies and services. This segment is known for its premium brands, proprietary private labels, specialty products, grooming, pet wash, and additional services, catering to the needs of pets and their owners.

  • Badcock

    A specialty retailer and franchisor in the furniture, appliances, bedding, electronics, home office equipment, accessories, and seasonal items sector. Badcock operates showroom formats and offers various flexible payment solutions and credit options for consumers.

  • American Freight

    This segment provides customers in-store and online access to furniture, mattresses, new and out-of-box home appliances, and home accessories. It also acts as a liquidation channel for appliance vendors, offering a wide range of products at discounted prices.

  • Buddy's

    Functions as a specialty retailer offering consumer electronics, residential furniture, appliances, and household accessories through rent-to-own agreements, thereby providing flexible ownership options for customers.

  • Sylvan

    Focused on supplemental education for Pre-K-12 students in the United States and Canada, Sylvan grows as a franchisor offering personalized tutoring in various subjects, thereby supporting students and families in their educational endeavors.

Contact Information

Address: 109 Innovation Court
Phone: 740 363 2222